India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected

The patent on the drug made India dependent on drug supplies from J&J, the latest decision will pave the way for generic versions in the local market, increasing access

Related Keywords

India ,Phumeza Tisile ,Johnson ,Narendra Modi ,Nandita Venkatesan ,Indian Patent Office ,Drug Administration ,Prime Minister Modi ,Prime Minister ,Sans Fronti ,Doctors Without Borders ,Tuberculosis ,J ,Tb Drug ,B Drug Price ,World Tb Day ,World Tuberculosis Day ,